Laboratory of Intracellular Parasites, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
PLoS Pathog. 2013;9(8):e1003556. doi: 10.1371/journal.ppat.1003556. Epub 2013 Aug 8.
The intracellular pathogenic bacterium Brucella generates a replicative vacuole (rBCV) derived from the endoplasmic reticulum via subversion of the host cell secretory pathway. rBCV biogenesis requires the expression of the Type IV secretion system (T4SS) VirB, which is thought to translocate effector proteins that modulate membrane trafficking along the endocytic and secretory pathways. To date, only a few T4SS substrates have been identified, whose molecular functions remain unknown. Here, we used an in silico screen to identify putative T4SS effector candidate proteins using criteria such as limited homology in other bacterial genera, the presence of features similar to known VirB T4SS effectors, GC content and presence of eukaryotic-like motifs. Using β-lactamase and CyaA adenylate cyclase reporter assays, we identified eleven proteins translocated into host cells by Brucella, five in a VirB T4SS-dependent manner, namely BAB1_0678 (BspA), BAB1_0712 (BspB), BAB1_0847 (BspC), BAB1_1671 (BspE) and BAB1_1948 (BspF). A subset of the translocated proteins targeted secretory pathway compartments when ectopically expressed in HeLa cells, and the VirB effectors BspA, BspB and BspF inhibited protein secretion. Brucella infection also impaired host protein secretion in a process requiring BspA, BspB and BspF. Single or combined deletions of bspA, bspB and bspF affected Brucella ability to replicate in macrophages and persist in the liver of infected mice. Taken together, these findings demonstrate that Brucella modulates secretory trafficking via multiple T4SS effector proteins that likely act coordinately to promote Brucella pathogenesis.
胞内致病菌布鲁氏菌通过颠覆宿主细胞的分泌途径,从内质网产生一个复制空泡(rBCV)。rBCV 的生物发生需要表达 IV 型分泌系统(T4SS)VirB,该系统被认为可转运效应蛋白,调节沿内吞和分泌途径的膜运输。迄今为止,仅鉴定出少数 T4SS 底物,其分子功能仍未知。在这里,我们使用计算机筛选来识别推定的 T4SS 效应子候选蛋白,使用的标准包括在其他细菌属中的同源性有限、存在与已知 VirB T4SS 效应子相似的特征、GC 含量和存在真核样基序。使用β-内酰胺酶和 CyaA 腺苷酸环化酶报告基因测定,我们鉴定了 11 种通过布鲁氏菌转运到宿主细胞的蛋白,其中 5 种以 VirB T4SS 依赖的方式转运,即 BAB1_0678(BspA)、BAB1_0712(BspB)、BAB1_0847(BspC)、BAB1_1671(BspE)和 BAB1_1948(BspF)。当在 HeLa 细胞中外源表达时,一组转位蛋白靶向分泌途径区室,并且 VirB 效应子 BspA、BspB 和 BspF 抑制蛋白分泌。布鲁氏菌感染也在需要 BspA、BspB 和 BspF 的过程中损害宿主蛋白分泌。bspA、bspB 和 bspF 的单个或组合缺失影响布鲁氏菌在巨噬细胞中的复制能力和在感染小鼠肝脏中的持续存在。总之,这些发现表明,布鲁氏菌通过多个 T4SS 效应蛋白来调节分泌运输,这些效应蛋白可能协同作用促进布鲁氏菌的发病机制。